Answers are grounded in this paper and cite their sources.
Multi-resonance thermally activated delayed fluorescence (MR-TADF) emitters have demonstrated remarkable potential in optoelectronic applications; however, their utilization in light-emitting electrochemical cells (LECs), particularly efficient red-emitting devices, remains largely unexplored. Herein, a series of donor–acceptor MR-TADF emitters based on a DiKTa acceptor and diphenylamine-derived donors were developed to investigate the influence of donor strength on the photophysical properties and LEC performance. The emitters exhibit orange-red to deep-red photoluminescence in toluene, peaking from lPL of 589 to 633 nm and their spectra having full widths at half-maxima (FWHMs) of 44–72 nm. Increasing donor strength progressively stabilizes the singlet excited state, leading to red-shifted emission, smaller singlet-triplet energy gaps, and accelerated reverse intersystem crossing. Among the series, PN1A-DiKTa has the highest photoluminescence quantum yield (ΦPL) of 70% in a 5 wt% doped film in mCP, whereas MeODPA-DiKTa emits furthers in the red with lPL of 655 nm. The MR-TADF emitters were evaluated in solution-processed and single-layer active material LECs, and the PN1A-DiKTa-based device delivered red electroluminescence (lEL = 610 nm) with a maximum external quantum efficiency (EQEmax) of 2.4% at a luminance of 270 cd/m2. This is one of the highest reported efficiencies for red LECs based on metal-free emitters.
No takes yet. Share an insight, caveat, or question.
Si et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: